kabutan

TOWA PHARMACEUTICAL CO.,LTD.(4553) Summary

4553
TSE Prime
TOWA PHARMACEUTICAL CO.,LTD.
3,350
JPY
+95
(+2.92%)
Dec 5, 12:44 pm JST
21.59
USD
Dec 4, 10:44 pm EST
Result
PTS
outside of trading hours
3,350.5
Dec 5, 12:44 pm JST
Summary Chart Historical News Financial Result
PER
9.3
PBR
0.92
Yield
2.39%
Margin Trading Ratio
4.96
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
3,270 JPY 21.07 USD
Previous Close Dec 4
3,255 JPY 20.94 USD
High Dec 5, 9:36 am
3,390 JPY 21.84 USD
Low Dec 5, 9:00 am
3,265 JPY 21.04 USD
Volume
148,200
Trading Value
0.49B JPY 3.18M USD
VWAP
3332.8 JPY 21.49 USD
Minimum Trading Value
335,000 JPY 2,159 USD
Market Cap
0.17T JPY 1.11B USD
Number of Trades
353
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
500
1-Year High May 16, 2025
2,469
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 37,400 91,900 2.46
Nov 21, 2025 36,500 107,100 2.93
Nov 14, 2025 31,900 128,500 4.03
Nov 7, 2025 32,200 141,000 4.38
Oct 31, 2025 33,900 141,200 4.17
Company Profile
TOWA PHARMACEUTICAL CO.,LTD. is a leading generic drug manufacturer with strengths in cardiovascular products. The company has expanded from serving clinics to pharmacies and has also entered the healthcare business.
Sector
Pharmaceuticals
TOWA PHARMACEUTICAL CO.,LTD. specializes in the manufacture and sale of prescription drugs, ranking among the top domestic producers of generic medicines, its main product line. The company directly sells its self-manufactured pharmaceuticals to medical institutions, as well as to distributors, pharmaceutical wholesalers, and other manufacturers. Through its group companies, TOWA is also involved in active pharmaceutical ingredient research and production, soft capsule manufacturing, and the planning, development, and contract manufacturing of health foods. Internationally, the company operates generic drug businesses in Europe and the United States through its holding company. Its group companies have research, development, and manufacturing bases in Europe, where they conduct generic drug sales and contract research, development, and manufacturing services.